Back to results
UnknownPhase 2

MW150 Stress Kinase Inhibitor in Mild to Moderate Alzheimer's Disease

NCT05194163

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Columbia University Irving Medical Center

New York, New York, United States

Contact

Lawrence S Honig, MD PhD

2123059194lh456@cumc.columbia.edu
View on ClinicalTrials.gov
MW150 Stress Kinase Inhibitor in Mild to Moderate Alzheimer's Disease — TrialFind